Direct evidence of a thymic abnormality in relapsing-remitting multiple sclerosis

被引：0
|
作者：
Williams, Julia [1 ]
Mason, Helen [1 ]
Lapierre, Yves [1 ]
Antel, Jack [1 ]
Haegert, David [1 ]
机构：
[1] McGill Univ, Montreal, PQ, Canada
来源：
JOURNAL OF NEUROIMMUNOLOGY | 2008年 / 203卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：136 / 137
页数：2
相关论文
共 50 条
  • [41] Daclizumab for the treatment of relapsing-remitting multiple sclerosis
    Herwerth, Marina
    Hemmer, Bernhard
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (06) : 747 - 753
  • [42] Minimal evidence of disease activity (MEDA) in relapsing-remitting multiple sclerosis
    Prosperini, Luca
    Mancinelli, Chiara
    Haggiag, Shalom
    Cordioli, Cinzia
    De Giglio, Laura
    De Rossi, Nicola
    Galgani, Simonetta
    Rasia, Sarah
    Ruggieri, Serena
    Tortorella, Carla
    Pozzilli, Carlo
    Gasperini, Claudio
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2020, 91 (03): : 271 - 277
  • [43] Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis
    Menge, Til
    Dubey, Divyanshu
    Warnke, Clemens
    Hartung, Hans-Peter
    Stuve, Olaf
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (10) : 1131 - 1139
  • [44] Development of laquinimod for relapsing-remitting multiple sclerosis
    Jeffery, Douglas R.
    FUTURE NEUROLOGY, 2008, 3 (06) : 641 - 648
  • [45] Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis
    Hersh, Carrie M.
    Cohen, Jeffrey A.
    IMMUNOTHERAPY, 2014, 6 (03) : 249 - 259
  • [46] Alemtuzumab in the treatment of relapsing-remitting multiple sclerosis
    Fox, Edward J.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (12) : 1789 - 1797
  • [47] Natalizumab in spinal relapsing-remitting multiple sclerosis
    Zecca, C.
    Kamm, C.
    Riccitelli, G. C.
    Heldner, M.
    Caporro, M.
    Gobbi, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 457 - 457
  • [48] Intravenous immunoglobulin in relapsing-remitting multiple sclerosis
    Achiron, A
    Barak, Y
    SarovaPinhas, I
    Achiron, R
    Gabbay, U
    Rotstein, Z
    Noy, S
    INTRAVENOUS IMMUNOGLOBULIN: RESEARCH AND THERAPY, 1996, : 289 - 293
  • [49] Cognitive Impairment In Relapsing-Remitting Multiple Sclerosis
    Topcular, Baris
    Ozcan, M. Emin
    Kurt, Elif
    Kuscu, Demet Yandim
    Icen, Nilufer Kale
    Sutlas, Pakize Nevin
    Kirbas, Dursun
    Bingol, Ayhan
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2012, 49 (03): : 178 - 182
  • [50] Oral fingolimod for relapsing-remitting multiple sclerosis
    Doggrell, Sheila A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (10) : 1777 - 1781
12345